Real-time enrollment status for this anaplastic astrocytoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:56 PM UTC
| NCT Number | NCT04623931 |
| Recruiting Status | Recruiting |
| Condition | Anaplastic Astrocytoma, IDH-Wildtype |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | January 14, 2026 (Jan 14, 2026) |
As of July 13, 2026: Clinical trial NCT04623931 is currently recruiting participants. This clinical trial study for anaplastic astrocytoma, idh-wildtype is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04623931 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04623931 was last updated Jan 14, 2026 (January 14, 2026). HelloStudys verifies this status automatically.